CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4 Open-market sale Chief Financial Officer sold 7,942 shares at $31.51 ($250,252)
- 4 Open-market sale SVP, Chief Accounting Officer sold 64 shares at $29.17 ($1,867)
- 4 Open-market sale EVP and Chief Legal Officer sold 2,450 shares at $31.17 ($76,367)
- 4 Open-market sale SVP, Chief Accounting Officer sold 84 shares at $31.39 ($2,637)
- 4 Planned sale Director sold 2,405 shares at $37.39 ($89,923)
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Grant or award Director acquired 5,740 shares (grant or award)
- 4 Open-market sale EVP and Chief Medical Officer sold 762 shares at an average $37.93 ($28,901)
- 4 Open-market sale Chief Financial Officer sold 1,785 shares at $40.40 ($72,114)
- 4 Open-market sale CBO & EVP sold 6,028 shares at $42.10 ($253,779)
- 4 Open-market sale EVP and Chief Legal Officer sold 12,846 shares at $42.10 ($540,817)
- 4 Open-market sale EVP and Chief Medical Officer sold 8,945 shares at $42.10 ($376,585)
- 4 Open-market sale Pinion John Richard sold 14,439 shares at $42.10 ($607,882)
- 4 Planned sale President & CEO sold 98,434 shares at an average $42.20 ($4,153,571)
- 4 Open-market sale EVP & Chief Commercial Officer sold 15,103 shares at $42.10 ($635,836)
Page 3 of 32 · 627 filings